Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 24,289 | 21,194 | 20,923 | 8,982 | 29 |
| Cost of Goods | 25,330 | 28,643 | 24,445 | 17,951 | N/A |
| Gross Profit | -1,041 | -7,449 | -3,522 | -8,969 | -11,358 |
| Operating Expenses | 71,755 | 64,815 | 58,140 | 57,222 | 75,893 |
| Operating Income | -72,466 | -71,621 | -61,217 | -65,240 | -75,864 |
| Interest Expense | 22,836 | 10,520 | -6,829 | 10,143 | -30,835 |
| Other Income | 3,788 | 3,555 | 6,868 | 7,447 | 18,886 |
| Pre-tax Income | -91,514 | -78,586 | -47,520 | -67,936 | -26,143 |
| Income Tax | -1,182 | 532 | 397 | 2,225 | 1,463 |
| Net Income Continuous | -90,332 | -79,118 | -47,917 | -70,161 | -27,606 |
| Net Income | $-90,332 | $-79,118 | $-47,917 | $-70,161 | $-27,606 |
| EPS Basic Total Ops | -0.34 | -0.30 | -0.18 | -0.26 | -0.09 |
| EPS Basic Continuous Ops | -0.34 | -0.30 | -0.18 | -0.26 | -0.10 |
| EPS Diluted Total Ops | -0.34 | -0.30 | -0.18 | -0.26 | -0.09 |
| EPS Diluted Continuous Ops | -0.34 | -0.30 | -0.18 | -0.26 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.34 | -0.30 | -0.18 | -0.26 | -0.09 |
| EBITDA(a) | $-69,835 | $-69,083 | $-58,849 | $-62,963 | $-73,787 |